11:36am - 12:21pm [CET]
With over 25 million people living with HIV, Africa has the highest burden of the pandemic. However, research conducted in Africa on HIV vaccines is often underrepresented in the global scientific literature, which can lead to missed opportunities for discovery and innovation.
Increased domestic funding for HIV prevention-related research can help support the development of local research capacity and promote innovation, as well as create jobs, attract investment and promote scientific and technological development.
Understanding the gaps, benefits and challenges of African domestic funding for HIV prevention research is crucial to building a sustainable research-based HIV response.